Wogonin	B:C0251223
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
signaling	O
pathways	I:C0037080
in	O
human	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	B:C0032098
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
signaling	O
pathways	I:C0037080
in	O
human	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	B:C0243095
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
signaling	O
pathways	I:C0037080
in	O
human	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	B:C1148560
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
signaling	O
pathways	I:C0037080
in	O
human	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	B:C0162772
/	O
ERK	O
/	O
Nrf2	O
signaling	O
pathways	I:C0037080
in	O
human	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	O
/	O
ERK	B:C0600388
/	O
Nrf2	O
signaling	O
pathways	I:C0037080
in	O
human	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	B:C0289507
signaling	O
pathways	I:C0037080
in	O
human	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
signaling	B:C0037080
pathways	I:C0037080
in	O
human	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
signaling	O
pathways	I:C0037080
in	O
human	B:C0086418
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
signaling	O
pathways	I:C0037080
in	O
human	O
Osteoarthritis	B:C0029408
chondrocytes	O
.	O

Wogonin	O
,	O
a	O
plant	O
derived	O
small	O
molecule	O
,	O
exerts	O
potent	O
anti-inflammatory	O
and	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
signaling	O
pathways	I:C0037080
in	O
human	O
Osteoarthritis	O
chondrocytes	B:C0225369
.	O

Osteoarthritis	B:C0029408
(	O
Osteoarthritis	O
)	O
,	O
characterized	O
by	O
progressive	O
destruction	O
of	O
articular	O
cartilage	I:C0007303
,	I:C0007303
is	O
the	O
most	O
common	O
form	O
of	O
human	O
arthritis	O
.	O

Osteoarthritis	O
(	O
Osteoarthritis	B:C0029408
)	O
,	O
characterized	O
by	O
progressive	O
destruction	O
of	O
articular	O
cartilage	I:C0007303
,	I:C0007303
is	O
the	O
most	O
common	O
form	O
of	O
human	O
arthritis	O
.	O

Osteoarthritis	O
(	O
Osteoarthritis	O
)	O
,	O
characterized	O
by	O
progressive	O
destruction	O
of	O
articular	B:C0007303
cartilage	I:C0007303
,	I:C0007303
is	O
the	O
most	O
common	O
form	O
of	O
human	O
arthritis	O
.	O

Osteoarthritis	O
(	O
Osteoarthritis	O
)	O
,	O
characterized	O
by	O
progressive	O
destruction	O
of	O
articular	O
cartilage	I:C0007303
,	I:C0007303
is	O
the	O
most	O
common	O
form	O
of	O
human	B:C0086418
arthritis	O
.	O

Osteoarthritis	O
(	O
Osteoarthritis	O
)	O
,	O
characterized	O
by	O
progressive	O
destruction	O
of	O
articular	O
cartilage	I:C0007303
,	I:C0007303
is	O
the	O
most	O
common	O
form	O
of	O
human	O
arthritis	B:C0003864
.	O

Here	O
,	O
we	O
evaluated	B:C0220825
the	O
potential	O
chondroprotective	O
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	O
,	O
a	O
naturally	O
occurring	O
flavonoid	O
,	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
potential	O
chondroprotective	B:C0243095
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	O
,	O
a	O
naturally	O
occurring	O
flavonoid	O
,	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
potential	O
chondroprotective	O
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	B:C0251223
,	O
a	O
naturally	O
occurring	O
flavonoid	O
,	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
potential	O
chondroprotective	O
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	O
,	O
a	O
naturally	O
occurring	O
flavonoid	B:C0596577
,	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
potential	O
chondroprotective	O
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	O
,	O
a	O
naturally	O
occurring	O
flavonoid	O
,	O
in	O
IL	B:C1702300
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
potential	O
chondroprotective	O
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	O
,	O
a	O
naturally	O
occurring	O
flavonoid	O
,	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	B:C0086418
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
potential	O
chondroprotective	O
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	O
,	O
a	O
naturally	O
occurring	O
flavonoid	O
,	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	O
Osteoarthritis	B:C0029408
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
potential	O
chondroprotective	O
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	O
,	O
a	O
naturally	O
occurring	O
flavonoid	O
,	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	O
Osteoarthritis	O
chondrocytes	B:C0225369
and	O
cartilage	O
explants	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
potential	O
chondroprotective	O
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	O
,	O
a	O
naturally	O
occurring	O
flavonoid	O
,	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	B:C0007303
explants	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
potential	O
chondroprotective	O
and	O
anti-inflammatory	O
effects	O
of	O
Wogonin	O
,	O
a	O
naturally	O
occurring	O
flavonoid	O
,	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
human	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	B:C0025080
.	O

Wogonin	B:C0251223
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	B:C0038855
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	B:C1171362
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	B:C3714634
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	B:C0243042
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	B:C1698754
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	B:C1565860
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	B:C0012472
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	B:C0669372
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	B:C0028128
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	B:C1702300
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	B:C0029408
chondrocytes	O
.	O

Wogonin	O
completely	O
suppressed	O
the	O
expression	O
and	O
production	O
of	O
inflammatory	O
mediators	I:C0243042
including	O
IL	O
-	I:C1698754
6	I:C1698754
,	O
COX	O
-	I:C1565860
2	I:C1565860
,	O
PGE2	O
,	O
iNOS	O
and	O
NO	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	B:C0225369
.	O

Further	O
,	O
Wogonin	B:C0251223
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	B:C0243095
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	B:C0037080
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	B:C1517052
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	B:C0699900
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	B:C0220781
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	B:C1171362
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	B:C3714634
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	B:C1517052
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	B:C1947941
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	B:C1567335
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	B:C1723257
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	B:C0165519
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	B:C4255123
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	B:C0029408
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	B:C0225369
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	B:C0119860
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	B:C1505419
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	B:C1702300
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	B:C0029408
cartilage	O
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	B:C0007303
explants	O
.	O

Further	O
,	O
Wogonin	O
exhibits	O
potent	O
chondroprotective	O
potential	O
by	O
switching	O
the	O
signaling	O
axis	I:C0037080
of	O
matrix	O
degradation	I:C1517052
from	O
catabolic	O
towards	O
anabolic	O
ends	I:C0220781
and	O
inhibited	O
the	O
expression	O
,	O
production	O
and	O
activities	O
of	O
matrix	O
degrading	I:C1517052
proteases	O
including	O
MMP	O
-	I:C1567335
13	I:C1567335
,	O
MMP	O
-	I:C1723257
3	I:C1723257
,	O
MMP	O
-	I:C0165519
9	I:C0165519
,	O
and	O
ADAMTS	O
-	I:C4255123
4	I:C4255123
in	O
Osteoarthritis	O
chondrocytes	O
,	O
and	O
blocked	O
the	O
release	O
of	O
s-GAG	O
and	O
COL2A1	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
cartilage	O
explants	B:C0025080
.	O

Wogonin	B:C0251223
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	B:C1171362
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	B:C0007303
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	B:C0220781
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	B:C1505419
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	B:C1429453
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	B:C0225369
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	B:C1702300
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	B:C1505419
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	B:C0033692
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	B:C0225371
of	I:C0225371
cartilage	I:C0225371
explants	O
.	O

Wogonin	O
also	O
elevated	O
the	O
expression	O
of	O
cartilage	O
anabolic	O
factors	O
COL2A1	O
and	O
ACAN	O
in	O
chondrocytes	O
and	O
inhibited	O
the	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
mediated	O
depletion	O
of	O
COL2A1	O
and	O
proteoglycan	O
content	O
in	O
the	O
matrix	O
of	I:C0225371
cartilage	I:C0225371
explants	B:C0025080
.	O

The	O
suppressive	B:C0038855
effect	O
of	O
Wogonin	O
was	O
not	O
mediated	O
through	O
the	O
inhibition	O
of	O
MAPKs	O
or	O
NF	O
-	I:C0079904
κB	I:C0079904
activation	O
.	O

The	O
suppressive	O
effect	O
of	O
Wogonin	B:C0251223
was	O
not	O
mediated	O
through	O
the	O
inhibition	O
of	O
MAPKs	O
or	O
NF	O
-	I:C0079904
κB	I:C0079904
activation	O
.	O

The	O
suppressive	O
effect	O
of	O
Wogonin	O
was	O
not	O
mediated	O
through	O
the	O
inhibition	O
of	O
MAPKs	B:C0752312
or	O
NF	O
-	I:C0079904
κB	I:C0079904
activation	O
.	O

The	O
suppressive	O
effect	O
of	O
Wogonin	O
was	O
not	O
mediated	O
through	O
the	O
inhibition	O
of	O
MAPKs	O
or	O
NF	B:C0079904
-	I:C0079904
κB	I:C0079904
activation	O
.	O

Instead	O
,	O
Wogonin	B:C0251223
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	B:C0242606
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	B:C3894443
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	B:C0007634
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	B:C0017817
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	B:C2754666
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	B:C0289507
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	B:C3494205
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	B:C0037080
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	B:C1148560
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	B:C0162772
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	B:C0600388
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	B:C0289507
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	B:C0538674
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	B:C0968147
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	B:C1136197
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	B:C1522376
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	B:C0037080
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	B:C0029408
chondrocytes	O
.	O

Instead	O
,	O
Wogonin	O
induced	O
mild	O
oxidative	O
stress	I:C0242606
through	O
the	O
generation	O
of	I:C3894443
ROS	I:C3894443
and	O
depletion	O
of	O
cellular	O
GSH	O
,	O
thereby	O
modulating	O
the	I:C2754666
cellular	I:C2754666
redox	I:C2754666
leading	O
to	O
the	O
induction	O
of	O
Nrf2	O
/	O
ARE	O
pathways	O
through	O
activation	O
of	O
ROS	O
/	O
ERK	O
/	O
Nrf2	O
/	O
HO	O
-	I:C0538674
1	I:C0538674
-	O
SOD2	O
-	O
NQO1	O
-	O
GCLC	O
signaling	O
axis	I:C0037080
in	O
Osteoarthritis	O
chondrocytes	B:C0225369
.	O

Molecular	B:C3494274
docking	I:C3494274
studies	I:C3494274
revealed	O
that	O
Wogonin	O
can	O
disrupt	O
KEAP	O
-	I:C3810577
1	I:C3810577
/	O
Nrf	O
-	I:C0289507
2	I:C0289507
interaction	O
by	O
directly	O
blocking	O
the	O
binding	O
site	I:C0005456
of	O
Nrf	O
-	I:C0289507
2	I:C0289507
in	O
the	O
KEAP	O
-	I:C3810577
1	I:C3810577
protein	I:C3810577
.	O

Molecular	O
docking	I:C3494274
studies	I:C3494274
revealed	O
that	O
Wogonin	B:C0251223
can	O
disrupt	O
KEAP	O
-	I:C3810577
1	I:C3810577
/	O
Nrf	O
-	I:C0289507
2	I:C0289507
interaction	O
by	O
directly	O
blocking	O
the	O
binding	O
site	I:C0005456
of	O
Nrf	O
-	I:C0289507
2	I:C0289507
in	O
the	O
KEAP	O
-	I:C3810577
1	I:C3810577
protein	I:C3810577
.	O

Molecular	O
docking	I:C3494274
studies	I:C3494274
revealed	O
that	O
Wogonin	O
can	O
disrupt	O
KEAP	B:C3810577
-	I:C3810577
1	I:C3810577
/	O
Nrf	O
-	I:C0289507
2	I:C0289507
interaction	O
by	O
directly	O
blocking	O
the	O
binding	O
site	I:C0005456
of	O
Nrf	O
-	I:C0289507
2	I:C0289507
in	O
the	O
KEAP	O
-	I:C3810577
1	I:C3810577
protein	I:C3810577
.	O

Molecular	O
docking	I:C3494274
studies	I:C3494274
revealed	O
that	O
Wogonin	O
can	O
disrupt	O
KEAP	O
-	I:C3810577
1	I:C3810577
/	O
Nrf	B:C0289507
-	I:C0289507
2	I:C0289507
interaction	O
by	O
directly	O
blocking	O
the	O
binding	O
site	I:C0005456
of	O
Nrf	O
-	I:C0289507
2	I:C0289507
in	O
the	O
KEAP	O
-	I:C3810577
1	I:C3810577
protein	I:C3810577
.	O

Molecular	O
docking	I:C3494274
studies	I:C3494274
revealed	O
that	O
Wogonin	O
can	O
disrupt	O
KEAP	O
-	I:C3810577
1	I:C3810577
/	O
Nrf	O
-	I:C0289507
2	I:C0289507
interaction	B:C0872079
by	O
directly	O
blocking	O
the	O
binding	O
site	I:C0005456
of	O
Nrf	O
-	I:C0289507
2	I:C0289507
in	O
the	O
KEAP	O
-	I:C3810577
1	I:C3810577
protein	I:C3810577
.	O

Molecular	O
docking	I:C3494274
studies	I:C3494274
revealed	O
that	O
Wogonin	O
can	O
disrupt	O
KEAP	O
-	I:C3810577
1	I:C3810577
/	O
Nrf	O
-	I:C0289507
2	I:C0289507
interaction	O
by	O
directly	O
blocking	O
the	O
binding	B:C0005456
site	I:C0005456
of	O
Nrf	O
-	I:C0289507
2	I:C0289507
in	O
the	O
KEAP	O
-	I:C3810577
1	I:C3810577
protein	I:C3810577
.	O

Molecular	O
docking	I:C3494274
studies	I:C3494274
revealed	O
that	O
Wogonin	O
can	O
disrupt	O
KEAP	O
-	I:C3810577
1	I:C3810577
/	O
Nrf	O
-	I:C0289507
2	I:C0289507
interaction	O
by	O
directly	O
blocking	O
the	O
binding	O
site	I:C0005456
of	O
Nrf	B:C0289507
-	I:C0289507
2	I:C0289507
in	O
the	O
KEAP	O
-	I:C3810577
1	I:C3810577
protein	I:C3810577
.	O

Molecular	O
docking	I:C3494274
studies	I:C3494274
revealed	O
that	O
Wogonin	O
can	O
disrupt	O
KEAP	O
-	I:C3810577
1	I:C3810577
/	O
Nrf	O
-	I:C0289507
2	I:C0289507
interaction	O
by	O
directly	O
blocking	O
the	O
binding	O
site	I:C0005456
of	O
Nrf	O
-	I:C0289507
2	I:C0289507
in	O
the	O
KEAP	B:C3810577
-	I:C3810577
1	I:C3810577
protein	I:C3810577
.	O

Genetic	O
ablation	B:C0547070
of	O
Nrf2	O
using	O
specific	O
siRNA	O
,	O
significantly	O
abrogated	O
the	O
anti-inflammatory	O
and	O
chondroprotective	O
potential	O
of	O
Wogonin	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Genetic	O
ablation	O
of	O
Nrf2	B:C1417701
using	O
specific	O
siRNA	O
,	O
significantly	O
abrogated	O
the	O
anti-inflammatory	O
and	O
chondroprotective	O
potential	O
of	O
Wogonin	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Genetic	O
ablation	O
of	O
Nrf2	O
using	O
specific	O
siRNA	B:C1099354
,	O
significantly	O
abrogated	O
the	O
anti-inflammatory	O
and	O
chondroprotective	O
potential	O
of	O
Wogonin	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Genetic	O
ablation	O
of	O
Nrf2	O
using	O
specific	O
siRNA	O
,	O
significantly	O
abrogated	O
the	O
anti-inflammatory	O
and	O
chondroprotective	B:C0243095
potential	O
of	O
Wogonin	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Genetic	O
ablation	O
of	O
Nrf2	O
using	O
specific	O
siRNA	O
,	O
significantly	O
abrogated	O
the	O
anti-inflammatory	O
and	O
chondroprotective	O
potential	O
of	O
Wogonin	B:C0251223
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Genetic	O
ablation	O
of	O
Nrf2	O
using	O
specific	O
siRNA	O
,	O
significantly	O
abrogated	O
the	O
anti-inflammatory	O
and	O
chondroprotective	O
potential	O
of	O
Wogonin	O
in	O
IL	B:C1702300
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	O
.	O

Genetic	O
ablation	O
of	O
Nrf2	O
using	O
specific	O
siRNA	O
,	O
significantly	O
abrogated	O
the	O
anti-inflammatory	O
and	O
chondroprotective	O
potential	O
of	O
Wogonin	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	B:C0029408
chondrocytes	O
.	O

Genetic	O
ablation	O
of	O
Nrf2	O
using	O
specific	O
siRNA	O
,	O
significantly	O
abrogated	O
the	O
anti-inflammatory	O
and	O
chondroprotective	O
potential	O
of	O
Wogonin	O
in	O
IL	O
-	I:C1702300
1	I:C1702300
β	I:C1702300
-	O
stimulated	O
Osteoarthritis	O
chondrocytes	B:C0225369
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	B:C0251223
exerts	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
suppression	O
of	O
molecular	O
events	O
involved	O
in	O
oxidative	O
stress	I:C0242606
,	O
inflammation	O
and	O
matrix	O
degradation	I:C1517052
in	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	O
exerts	O
chondroprotective	B:C0243095
effects	I:C0243095
through	O
the	O
suppression	O
of	O
molecular	O
events	O
involved	O
in	O
oxidative	O
stress	I:C0242606
,	O
inflammation	O
and	O
matrix	O
degradation	I:C1517052
in	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	O
exerts	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
suppression	B:C0038855
of	O
molecular	O
events	O
involved	O
in	O
oxidative	O
stress	I:C0242606
,	O
inflammation	O
and	O
matrix	O
degradation	I:C1517052
in	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	O
exerts	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
suppression	O
of	O
molecular	O
events	O
involved	O
in	O
oxidative	B:C0242606
stress	I:C0242606
,	O
inflammation	O
and	O
matrix	O
degradation	I:C1517052
in	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	O
exerts	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
suppression	O
of	O
molecular	O
events	O
involved	O
in	O
oxidative	O
stress	I:C0242606
,	O
inflammation	B:C0021368
and	O
matrix	O
degradation	I:C1517052
in	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	O
exerts	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
suppression	O
of	O
molecular	O
events	O
involved	O
in	O
oxidative	O
stress	I:C0242606
,	O
inflammation	O
and	O
matrix	B:C1517052
degradation	I:C1517052
in	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	O
exerts	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
suppression	O
of	O
molecular	O
events	O
involved	O
in	O
oxidative	O
stress	I:C0242606
,	O
inflammation	O
and	O
matrix	O
degradation	I:C1517052
in	O
Osteoarthritis	B:C0029408
chondrocytes	O
and	O
cartilage	O
explants	O
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	O
exerts	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
suppression	O
of	O
molecular	O
events	O
involved	O
in	O
oxidative	O
stress	I:C0242606
,	O
inflammation	O
and	O
matrix	O
degradation	I:C1517052
in	O
Osteoarthritis	O
chondrocytes	B:C0225369
and	O
cartilage	O
explants	O
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	O
exerts	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
suppression	O
of	O
molecular	O
events	O
involved	O
in	O
oxidative	O
stress	I:C0242606
,	O
inflammation	O
and	O
matrix	O
degradation	I:C1517052
in	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	B:C0007303
explants	O
.	O

Our	O
data	O
indicates	O
that	O
Wogonin	O
exerts	O
chondroprotective	O
effects	I:C0243095
through	O
the	O
suppression	O
of	O
molecular	O
events	O
involved	O
in	O
oxidative	O
stress	I:C0242606
,	O
inflammation	O
and	O
matrix	O
degradation	I:C1517052
in	O
Osteoarthritis	O
chondrocytes	O
and	O
cartilage	O
explants	B:C0025080
.	O

The	O
study	O
provides	O
novel	O
insights	O
into	O
the	O
development	O
of	O
Nrf2	B:C0289507
as	O
a	O
promising	O
candidate	O
and	O
Wogonin	O
as	O
a	O
therapeutic	O
agent	I:C1611640
for	O
the	O
management	O
of	O
Osteoarthritis	O
.	O

The	O
study	O
provides	O
novel	O
insights	O
into	O
the	O
development	O
of	O
Nrf2	O
as	O
a	O
promising	O
candidate	O
and	O
Wogonin	B:C0251223
as	O
a	O
therapeutic	O
agent	I:C1611640
for	O
the	O
management	O
of	O
Osteoarthritis	O
.	O

The	O
study	O
provides	O
novel	O
insights	O
into	O
the	O
development	O
of	O
Nrf2	O
as	O
a	O
promising	O
candidate	O
and	O
Wogonin	O
as	O
a	O
therapeutic	B:C1611640
agent	I:C1611640
for	O
the	O
management	O
of	O
Osteoarthritis	O
.	O

The	O
study	O
provides	O
novel	O
insights	O
into	O
the	O
development	O
of	O
Nrf2	O
as	O
a	O
promising	O
candidate	O
and	O
Wogonin	O
as	O
a	O
therapeutic	O
agent	I:C1611640
for	O
the	O
management	B:C0376636
of	O
Osteoarthritis	O
.	O

The	O
study	O
provides	O
novel	O
insights	O
into	O
the	O
development	O
of	O
Nrf2	O
as	O
a	O
promising	O
candidate	O
and	O
Wogonin	O
as	O
a	O
therapeutic	O
agent	I:C1611640
for	O
the	O
management	O
of	O
Osteoarthritis	B:C0029408
.	O

